Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Aug 04 2014

Some Statistics on Hospitalizations

By Kevin Roche Commentary No Comments
An Agency for Healthcare Research & Quality Statistical Brief gives us data on inpatient hospital costs and utilization from 2003 and 2013 and a projection about the future.
Read More
Aug 01 2014

FDA Regulation of Mobile Health

By Kevin Roche Commentary No Comments
The New England Journal of Medicine carries a thoughtful article on FDA regulation of "mobile health" technologies.
Read More
Jul 31 2014

The Consumer Share of Health Spending Growth

By Kevin Roche Commentary No Comments
A paper sponsored by the American Federation of Hospitals explores the apparent contrast between falling rates of health spending growth and increased health costs for consumers.
Read More
Jul 30 2014

The Reform Law’s Health Insurance Exchanges

By Kevin Roche Commentary No Comments
After discussing private health insurance exchanges yesterday, today we look into a few recent issues on the public exchanges.
Read More
Jul 29 2014

Private Health Insurance Exchange Growth

By Kevin Roche Commentary No Comments
A brief Accenture report describes the rapid growth in private health insurance exchanges and the factors behind that growth.
Read More
Jul 28 2014

FDA Consideration and Approval of New Drugs

By Kevin Roche Commentary No Comments
Studies in the Journal of the American Medical Association look at the evidence behind FDA approval of new drugs and at the reasons for delay or denials of approval.
Read More
Jul 25 2014

Medicare Beneficiary Out-of-Pocket Spending

By Kevin Roche Commentary No Comments
A brief from the Kaiser Family Foundation looks at out-of-pocket spending by Medicare Beneficiaries, including premiums and service cost-sharing. For some seniors, these numbers are pretty large.
Read More
Jul 24 2014

Comparative Drug Prices

By Kevin Roche Commentary No Comments
The Government Accounting Office reviews drug spending for DOD, Medicare and Medicaid; finding that Medicaid generally paid the lowest prices, in some cases substantially lower.
Read More
Jul 23 2014

Updating Practice Guidelines

By Kevin Roche Commentary No Comments
Keeping guidelines consistent with the latest scientific evidence may not be happening as consistently as it should be, according to research in the Journal of the American Medical Association.
Read More
Jul 22 2014

Cost Drivers in Massachusetts

By Kevin Roche Commentary No Comments
A report from the Massachusetts Association of Health Plans summarizes what has been learned in the state about its ongoing growth in health spending.
Read More
  • « Previous
  • 1
  • …
  • 501
  • 502
  • 503
  • 504
  • 505
  • …
  • 642
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

IKS Health, a British company with a US subsidiary that offers “care enablement” and mentions AI, of course,  is buying TruBridge for $557 million.  TruBridge offers revenue cycle management and...
April 30, 2026
Innovacer, which basically collects data on a patient from multiple sources and aggregates it, raised an astounding $275 million in new capital, supposedly at a valuation of almost $3.5 billion....
April 22, 2026
A company called Whoop raised a ridiculous $575 million in new capital at a supposed $10 billion valuation.  The press release was released on April 1, so I would like...
April 5, 2026
Big deals continue in health care financings.  eMed, which manages weight loss medications for employers, raises a hefty $200 million, giving it a valuation of $2 billion, which seems crazy....
March 31, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1844) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Health Affairs
  • Congressional Budget Office

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts